Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SIRONA DENTAL SYSTEMS, INC. (SIRO)
|
Add to portfolio |
|
|
|
| Price: |
$49.43
| | Metrics |
| OS: |
56.0
|
M
| |
14
|
% ROE
|
| Market cap: |
$2.77
|
B
| |
53
|
% ROIC
|
|
Net cash:
|
$427
|
M
| |
$7.62
|
per share
|
|
EV:
|
$2.34
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$331
|
M
| |
7.1
|
x EV/EBITDA
|
|
EBIT
|
$263
|
M
| |
8.9
|
x EV/EBIT
|
| EPS |
$3.48
| |
14.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-15 | Sep-30-14 | Sep-30-13 | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 |
| Revenues | 1,161.3 | 1,171.1 | 1,101.5 | 979.4 | 913.9 | 770.3 | 713.3 | 757.1 |
| Revenue growth | -0.8% | 6.3% | 12.5% | 7.2% | 18.6% | 8.0% | -5.8% | 14.7% |
| Cost of goods sold | 513.1 | 529.4 | 510.1 | 455.4 | 430.2 | 371.3 | 367.2 | 411.5 |
| Gross profit | 648.2 | 641.7 | 591.4 | 524.0 | 483.7 | 399.0 | 346.1 | 345.6 |
| Gross margin | 55.8% | 54.8% | 53.7% | 53.5% | 52.9% | 51.8% | 48.5% | 45.7% |
| Selling, general and administrative | 344.1 | 350.9 | 332.8 | 295.6 | 277.1 | 235.9 | 225.4 | 242.3 |
| Research and development | 54.8 | 64.6 | 60.2 | 52.6 | 55.5 | 46.4 | 40.6 | 48.7 |
| EBIT | 259.0 | 238.1 | 217.2 | 185.8 | 160.9 | 128.1 | 85.1 | 63.8 |
| EBIT margin | 22.3% | 20.3% | 19.7% | 19.0% | 17.6% | 16.6% | 11.9% | 8.4% |
| Pre-tax income | 242.9 | 230.4 | 197.5 | 178.3 | 159.5 | 115.2 | 63.3 | 38.9 |
| Income taxes | 54.8 | 53.0 | 49.0 | 42.7 | 35.7 | 0.0 | 0.0 | 9.3 |
| Tax rate | 22.6% | 23.0% | 24.8% | 23.9% | 22.4% | 0.0% | 0.0% | 24.0% |
| Net income | 190.0 | 179.1 | 150.3 | 137.4 | 121.8 | 90.0 | 53.4 | 29.6 |
| Net margin | 16.4% | 15.3% | 13.6% | 14.0% | 13.3% | 11.7% | 7.5% | 3.9% |
| |
| Diluted EPS | $3.37 | $3.19 | $2.67 | $2.42 | $2.13 | $1.59 | $0.96 | $0.54 |
| Shares outstanding (diluted) | 56.4 | 56.2 | 56.2 | 56.8 | 57.3 | 56.6 | 55.4 | 55.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|